Corvus Pharmaceuticals, Inc. (CRVS)

NGM – Real Time Price. Currency in USD

15.09

+0.36 (2.44%)

Market open: Aug 12, 2026, 3:26 PM EDT

14.77

+0.04 (0.27%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-105K

-85K

-151K

-367K

Gross Profit

-105K

-85K

-151K

-367K

Operating expenses (excl. COGS)

-43M

-27M

-23M

-32M

Operating Income

-43M

-28M

-23M

-33M

Non-operating income, total

28M

-35M

-4M

-9M

Pretax income

-15M

-62M

-27M

-41M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-15M

-62M

-27M

-41M

Discontinued operations

Net income

-15M

-62M

-27M

-41M

Dilution adjustment

-27M

Preferred dividends

Corvus Pharmaceuticals, Inc. (CRVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Corvus Pharmaceuticals, Inc. (CRVS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Corvus Pharmaceuticals, Inc. (CRVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Corvus Pharmaceuticals, Inc. (CRVS)

Income Statement (Annual)

Income Statement (Annual)